Articles from StockStory

Homebuilder KB Home (NYSE:KBH) will be reporting earnings tomorrow afternoon. Here’s what to look for.

Shares of aerospace and defense company Boeing (NYSE:BA) jumped 5.7% in the afternoon session after the company announced that it secured the contract to produce the next generation of fighter jets for the U.S. military, successfully outbidding competitor Lockheed Martin. The contract, known as Next Generation Air Dominance, or NGAD, is supposed to help build jets (F-47) that will accompany a future fleet of drone aircraft to protect the US against its adversaries. According to the press release, the contract is worth an estimated $20 billion.

Shares of athletic apparel brand Nike (NYSE:NKE) fell 8.5% in the pre-market session after the company reported third-quarter (fiscal 2025) results which came in soft, showing that the company's turnaround was still a work in progress. Sales continued to fall, and, margins shrunk underscoring ongoing challenges. Revenue, when adjusted for currency fluctuations, fell 7% year-over-year, a sharp contrast to flat growth in the same quarter last year. 

Shares of educational publishing and media company Scholastic (NASDAQ:SCHL) jumped 15.2% in the morning session after the company delivered strong first-quarter (fiscal Q3 2025) results, with profits significantly exceeding expectations as both EPS and EBITDA outperformed Wall Street's estimates. 

Shares of security and Aerospace company Lockheed Martin (NYSE:LMT) fell 7% in the afternoon session after the company lost the contract to produce the next generation of fighter jets for the U.S. military, which was awarded to Boeing. The contract, known as Next Generation Air Dominance, or NGAD, is supposed to help build jets ( F-47) that will accompany a future fleet of drone aircraft to protect the US against its adversaries. According to the press release, the contract is worth an estimated $20 billion.

Shares of memory chips maker Micron (NYSE:MU) fell 8.8% in the afternoon session after the company reported first-quarter (fiscal Q2 2025) results, which came with high expectations, but while the overall performance was decent, softness in key markets, weaker margins, and inventory concerns overshadowed the positives. 

Shares of homebuilder Lennar (NYSE:LEN) fell 6.7% in the morning session after the company reported weak first-quarter 2025 results, with its backlog declining 22% year over year, raising concerns about the strength of its near-term sales pipeline. 

Shares of earth imaging satellite company Planet Labs (NYSE:PL) fell 22.6% in the morning session after the company reported weak fourth-quarter (fiscal 2025) results: Its full-year revenue and EBITDA guidance missed significantly along with this quarter's revenue and EPS. 

Shares of women’s plus-size apparel retailer Torrid Holdings (NYSE:CURV) jumped 9% in the morning session after the company reported strong fourth-quarter 2024 results, which blew past analysts' estimates for sales, earnings, and operating profits. 

Shares of parcel and cargo delivery company FedEx (NYSE:FDX) fell 10.8% in the morning session after the company reported weak first-quarter (fiscal Q3 2025) results: its EPS and EBITDA fell short of Wall Street's estimates. 

Cruise ship company Carnival (NYSE:CCL) beat Wall Street’s revenue expectations in Q1 CY2025, with sales up 7.5% year on year to $5.81 billion. Its non-GAAP profit of $0.13 per share was significantly above analysts’ consensus estimates.

Business services providers thrive by solving complex operational challenges for their clients, allowing them to focus on their secret sauce. But cutbacks in corporate spending and the threat of new AI products have kept sentiment in check, and over the past six months, the industry has tumbled by 2.3%. This performance mirrored the S&P 500’s decline.

Even if they go mostly unnoticed, industrial businesses are the backbone of our country. But they are at the whim of volatile macroeconomic factors that influence capital spending (like interest rates), and the market seems convinced that demand will slow. Due to this bearish outlook, the industry has tumbled by 7.6% over the past six months. This drop was worse than the S&P 500’s 1.8% loss.

Even if they go mostly unnoticed, industrial businesses are the backbone of our country. Still, their generally high capital requirements expose them to the ups and downs of economic cycles, and the market seems to be baking in a prolonged downturn as the industry has shed 7.6% over the past six months. This drawdown was worse than the S&P 500’s 1.8% fall.

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. But financial performance has lagged recently as players offloaded surplus COVID inventories in 2023 and 2024, a headwind for overall demand. The result? Over the past six months, the industry has tumbled by 9.2%. This performance was worse than the S&P 500’s 1.8% loss.

Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.

Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in this part of the market, but it is also a high-risk, high-reward environment due to the lack of reliable analyst price targets.

Business services providers use their specialized expertise to help enterprises streamline operations and cut costs. But cutbacks in corporate spending and the threat of new AI products have kept sentiment in check, and over the past six months, the industry has tumbled by 2.3%. This drop mirrored the S&P 500’s decline.

Many investors pay attention to mid-cap stocks because they have established business models and expansive market opportunities. However, their paths to becoming $100 billion corporations are ripe with competition, ranging from giants with vast resources to agile upstarts eager to disrupt the status quo.

Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from scaled industry giants and can be disrupted by new innovative players vying for a slice of the pie.

The low valuation multiples for value stocks provide a margin of safety that growth stocks rarely offer. However, the challenge lies in determining whether these cheap assets are genuinely undervalued or simply on sale due to their potentially deteriorating business models.

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory destocking have harmed the industry’s returns - over the past six months, healthcare stocks have collectively shed 9.1%. This drop was worse than the S&P 500’s 1.8% loss.

Small-cap stocks can be incredibly lucrative investments because their lack of analyst coverage leads to frequent mispricings. However, these businesses (and their stock prices) often stay small because their subscale operations make it harder to expand their competitive moats.

Dover currently trades at $181.55 per share and has shown little upside over the past six months, posting a small loss of 5%.

What a brutal six months it’s been for JELD-WEN. The stock has dropped 61.7% and now trades at $6.11, rattling many shareholders. This might have investors contemplating their next move.

Enpro currently trades at $172.52 and has been a dream stock for shareholders. It’s returned 426% since March 2020, nearly tripling the S&P 500’s 152% gain. The company has also beaten the index over the past six months as its stock price is up 8.8% thanks to its solid quarterly results.

Looking back on leisure facilities stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Live Nation (NYSE:LYV) and its peers.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Royalty Pharma (NASDAQ:RPRX) and the rest of the branded pharmaceuticals stocks fared in Q4.

As the Q4 earnings season wraps, let’s dig into this quarter’s best and worst performers in the beverages, alcohol, and tobacco industry, including Celsius (NASDAQ:CELH) and its peers.

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the agricultural machinery industry, including Deere (NYSE:DE) and its peers.

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Chart (NYSE:GTLS) and its peers.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at traditional fast food stocks, starting with Wendy's (NASDAQ:WEN).

Over the past six months, Match Group’s shares (currently trading at $31.64) have posted a disappointing 14% loss while the S&P 500 was down 1.4%. This was partly due to its softer quarterly results and might have investors contemplating their next move.

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the heavy transportation equipment stocks, including Wabash (NYSE:WNC) and its peers.

Since September 2024, Red Robin has been in a holding pattern, posting a small loss of 3% while floating around $4.25.

Although the S&P 500 is down 1.4% over the past six months, Tennant’s stock price has fallen further to $84.99, losing shareholders 9% of their capital. This was partly due to its softer quarterly results and might have investors contemplating their next move.

NeoGenomics has gotten torched over the last six months - since September 2024, its stock price has dropped 36.8% to $9.98 per share. This may have investors wondering how to approach the situation.

Air Lease currently trades at $47 per share and has shown little upside over the past six months, posting a middling return of 3.9%. However, the stock is beating the S&P 500’s 1.4% decline during that period.

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Post (NYSE:POST) and its peers.

Although the S&P 500 is down 1.4% over the past six months, Utz’s stock price has fallen further to $13.89, losing shareholders 19.4% of their capital. This may have investors wondering how to approach the situation.

LKQ has been treading water for the past six months, recording a small return of 2.3% while holding steady at $41.06.

Over the last six months, Northrop Grumman shares have sunk to $489.24, producing a disappointing 8.2% loss - worse than the S&P 500’s 1.4% drop. This was partly due to its softer quarterly results and might have investors contemplating their next move.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how electrical systems stocks fared in Q4, starting with Thermon (NYSE:THR).

Over the last six months, Array shares have sunk to $5.70, producing a disappointing 10.5% loss - worse than the S&P 500’s 1.4% drop. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

Although the S&P 500 is down 1.4% over the past six months, Alight’s stock price has fallen further to $6.01, losing shareholders 18% of their capital. This was partly due to its softer quarterly results and might have investors contemplating their next move.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at aerospace and defense stocks, starting with Cadre (NYSE:CDRE).

Shareholders of Cars.com would probably like to forget the past six months even happened. The stock dropped 31.7% and now trades at $12.09. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

In a sliding market, 8x8 has defied the odds, trading up to $2.18 per share. Its 13% gain since September 2024 has outpaced the S&P 500’s 1.4% drop. This run-up might have investors contemplating their next move.

Over the past six months, Hanesbrands’s shares (currently trading at $6.03) have posted a disappointing 10% loss while the S&P 500 was down 1.4%. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how aerospace stocks fared in Q4, starting with Boeing (NYSE:BA).

Over the past six months, Vishay Intertechnology’s shares (currently trading at $17.15) have posted a disappointing 7.2% loss while the S&P 500 was down 1.4%. This was partly driven by its softer quarterly results and might have investors contemplating their next move.

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at Norwegian Cruise Line (NYSE:NCLH) and the best and worst performers in the travel and vacation providers industry.

What a brutal six months it’s been for Regeneron. The stock has dropped 39.3% and now trades at $662.80, rattling many shareholders. This might have investors contemplating their next move.

Over the last six months, Light & Wonder shares have sunk to $104.34, producing a disappointing 7.4% loss - worse than the S&P 500’s 1.4% drop. This might have investors contemplating their next move.

What a time it’s been for VSE Corporation. In the past six months alone, the company’s stock price has increased by a massive 44%, reaching $120 per share. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

Let’s dig into the relative performance of Insulet (NASDAQ:PODD) and its peers as we unravel the now-completed Q4 patient monitoring earnings season.

Looking back on it services & other tech stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Amdocs (NASDAQ:DOX) and its peers.

As the Q4 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the therapeutics industry, including BioMarin Pharmaceutical (NASDAQ:BMRN) and its peers.

Earnings results often indicate what direction a company will take in the months ahead. With Q4 behind us, let’s have a look at Option Care Health (NASDAQ:OPCH) and its peers.

Although the S&P 500 is down 1.4% over the past six months, Akamai’s stock price has fallen further to $81.54, losing shareholders 19% of their capital. This was partly due to its softer quarterly results and might have investors contemplating their next move.

Over the last six months, Vital Farms shares have sunk to $29.92, producing a disappointing 12.8% loss - worse than the S&P 500’s 1.4% drop. This might have investors contemplating their next move.

BlackLine has been treading water for the past six months, recording a small loss of 3.7% while holding steady at $49.33.

Since September 2024, CarGurus has been in a holding pattern, floating around $29.75.

Looking back on industrial & environmental services stocks’ Q4 earnings, we examine this quarter’s best and worst performers, including Cintas (NASDAQ:CTAS) and its peers.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how real estate services stocks fared in Q4, starting with Redfin (NASDAQ:RDFN).

Quarterly earnings results are a good time to check in on a company’s progress, especially compared to its peers in the same sector. Today we are looking at UFP Industries (NASDAQ:UFPI) and the best and worst performers in the building materials industry.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how surgical equipment & consumables - diversified stocks fared in Q4, starting with Solventum (NYSE:SOLV).

What a brutal six months it’s been for Desktop Metal. The stock has dropped 46.3% and now trades at $2.42, rattling many shareholders. This was partly due to its softer quarterly results and may have investors wondering how to approach the situation.

Wrapping up Q4 earnings, we look at the numbers and key takeaways for the drug development inputs & services stocks, including Medpace (NASDAQ:MEDP) and its peers.

MYR Group currently trades at $124.23 and has been a dream stock for shareholders. It’s returned 506% since March 2020, more than tripling the S&P 500’s 152% gain. The company has also beaten the index over the past six months as its stock price is up 24.4% thanks to its solid quarterly results.

What a fantastic six months it’s been for Kyndryl. Shares of the company have skyrocketed 44.9%, hitting $34.22. This was partly due to its solid quarterly results, and the run-up might have investors contemplating their next move.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at semiconductors stocks, starting with Seagate Technology (NASDAQ:STX).

Let’s dig into the relative performance of iHeartMedia (NASDAQ:IHRT) and its peers as we unravel the now-completed Q4 broadcasting earnings season.

As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q4. Today, we are looking at modern fast food stocks, starting with CAVA (NYSE:CAVA).